Lindbrook Capital, LLC Celldex Therapeutics, Inc. Transaction History

Lindbrook Capital, LLC

  • $1.18 Billion
  • Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 165 shares of CLDX stock, worth $4,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165
Previous 155 6.45%
Holding current value
$4,456
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$32.06 - $44.56 $320 - $445
10 Added 6.45%
165 $5,000
Q4 2023

Jan 31, 2024
BUY
$22.61 - $40.65 $3,504 - $6,300
155 New
155 $6,000
Q3 2023

Oct 25, 2023
SELL
$25.45 - $37.46 $1,374 - $2,022
-54 Closed
0 $0
Q2 2023

Jul 28, 2023
BUY
$30.29 - $38.28 $333 - $421
11 Added 25.58%
54 $1,000
Q1 2023

Apr 26, 2023
SELL
$34.78 - $47.43 $1,252 - $1,707
-36 Reduced 45.57%
43 $1,000
Q4 2022

Jan 24, 2023
BUY
$27.78 - $45.38 $2,111 - $3,448
76 Added 2533.33%
79 $0
Q3 2022

Nov 10, 2022
SELL
$22.7 - $37.57 $136 - $225
-6 Reduced 66.67%
3 $0
Q2 2022

Aug 01, 2022
SELL
$20.5 - $37.33 $881 - $1,605
-43 Reduced 82.69%
9 $0
Q1 2022

Apr 21, 2022
BUY
$27.64 - $39.32 $1,437 - $2,044
52 New
52 $2,000
Q4 2021

Jan 18, 2022
SELL
$35.68 - $56.27 $35,323 - $55,707
-990 Closed
0 $0
Q3 2021

Nov 05, 2021
BUY
$28.95 - $55.99 $28,660 - $55,430
990 New
990 $53,000
Q2 2021

Jul 27, 2021
SELL
$20.71 - $35.37 $20,710 - $35,370
-1,000 Closed
0 $0
Q1 2021

Apr 28, 2021
BUY
$16.19 - $29.91 $16,190 - $29,910
1,000 New
1,000 $21,000
Q3 2020

Nov 03, 2020
SELL
$9.65 - $15.19 $15,613 - $24,577
-1,618 Closed
0 $0
Q2 2020

Jul 27, 2020
BUY
$1.61 - $13.41 $2,604 - $21,697
1,618 New
1,618 $21,000

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.26B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email